Robert H Mead, MD
Cardiac Electrophysiology · East Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Community Hospital of the Monterey Peninsula · Mills-Peninsula Medical Center · Sequoia Hospital · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mead’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G41464 · Current
Licensed to practise in California · since 1980 · expires 2027-10-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$489,315
Medicare paid this office $489,315 for 1,659 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 522 | $137,600 | $158 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 126 | $72,966 | $549 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 67 | $32,744 | $252 |
| Return visit (30+ min) | 264 | $29,838 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 134 | $25,764 | $183 |
See all 35 services
| Long return visit (40+ min) | 522 | $137,600 | $158 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 126 | $72,966 | $549 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 67 | $32,744 | $252 |
| Return visit (30+ min) | 264 | $29,838 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 134 | $25,764 | $183 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 53 | $17,496 | $250 |
| New patient visit (60+ min) | 91 | $17,433 | $192 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 727 | $15,109 | $13 |
| Programming of dual lead pacemaker system | 95 | $13,748 | $76 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 200 | $10,944 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 54 | $10,540 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 158 | $9,515 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $8,105 | $100 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 458 | $7,525 | $15 |
| Long return visit (40+ min) | 54 | $7,347 | $127 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 25 | $5,545 | $222 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,082 | $151 |
| Removal and replacement of dual lead permanent pacemaker | 13 | $4,007 | $308 |
| Programming of multiple lead implantable defibrillator system | 15 | $3,337 | $101 |
| Programming of heart rhythm stimulation after drug infusion | 55 | $3,273 | $57 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 43 | $3,152 | $28 |
| Programming of dual lead implantable defibrillator system | 21 | $3,065 | $93 |
| New patient visit (45+ min) | 22 | $3,015 | $137 |
| External shock to heart to regulate heart beat | 29 | $2,911 | $91 |
| Programming of multiple lead pacemaker system | 18 | $2,854 | $82 |
| Return visit (30+ min) | 19 | $1,744 | $87 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 61 | $1,560 | $22 |
| 3d radiographic procedure | 58 | $1,511 | $26 |
| Programming of single lead pacemaker system | 15 | $1,450 | $60 |
| Short return visit (20+ min) | 11 | $1,129 | $81 |
| Measurement of heart blood flow and respiration | 30 | $1,083 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 57 | $865 | $13 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 43 | $837 | $19 |
| Heart muscle strain imaging | 16 | $617 | $39 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 43 | $521 | $12 |
Procedures Medicare counted
| Pacemaker insertion or repair | 12 | More than 63% of doctors who do this |
Who their Medicare patients are
1,659 Original Medicare patients in 2024. Average age 79 · Under 65 1% · 85 and older 25% · Women 45% · Also on Medicaid 2% · Health risk score 1.19. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 51% · Coronary heart disease 49% · Heart failure 25% · Chronic kidney disease 24% · Diabetes 20% · Cancer 19% · COPD 12% · Depression 11% · Stroke 8% · Dementia 6%.
The office billed $2,265,163, Medicare allowed $647,859 and paid $489,315; for 5,853 services of 79 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,659 | 5,853 | 79 | 1.19 | $2,265,163 | $489,315 |
| 2023 | 1,740 | 5,637 | 79 | 1.21 | $2,040,322 | $463,098 |
| 2022 | 1,062 | 4,591 | 78 | 1.16 | $1,954,458 | $477,662 |
| 2021 | 972 | 4,959 | 78 | 1.18 | $2,031,829 | $517,958 |
| 2020 | 931 | 5,072 | 78 | 1.32 | $1,656,661 | $411,197 |
| 2019 | 998 | 6,039 | 78 | 1.40 | $1,981,345 | $461,276 |
| 2018 | 933 | 5,956 | 78 | 1.38 | $2,055,555 | $489,478 |
| 2017 | 968 | 5,163 | 78 | 1.38 | $2,062,730 | $504,587 |
| 2016 | 950 | 4,898 | 78 | 1.49 | $1,848,628 | $444,573 |
| 2015 | 979 | 5,044 | 78 | 1.46 | $2,069,450 | $530,466 |
| 2014 | 869 | 4,547 | 78 | 1.45 | $1,936,781 | $480,571 |
| 2013 | 871 | 4,812 | 78 | 1.44 | $1,903,579 | $466,602 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 37 services
| Long return visit (40+ min) | 319 | $76,448 | $154 |
| Return visit (30+ min) | 550 | $74,709 | $106 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 104 | $70,114 | $655 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 144 | $29,181 | $192 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 64 | $21,210 | $219 |
| Programming of dual lead pacemaker system | 111 | $16,903 | $77 |
| New patient visit (60+ min) | 84 | $15,998 | $190 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 736 | $15,555 | $13 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 54 | $12,609 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $11,416 | $106 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 47 | $10,931 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 204 | $10,655 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 165 | $8,880 | $23 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 35 | $8,368 | $239 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,411 | $451 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,031 | $152 |
| Programming of heart rhythm stimulation after drug infusion | 65 | $4,528 | $69 |
| External shock to heart to regulate heart beat | 35 | $4,316 | $98 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 41 | $3,675 | $21 |
| Programming of dual lead implantable defibrillator system | 21 | $3,542 | $96 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 43 | $3,327 | $29 |
| Programming of multiple lead implantable defibrillator system | 17 | $3,142 | $98 |
| New patient visit (45+ min) | 24 | $3,079 | $128 |
| Return visit (30+ min) | 32 | $2,717 | $85 |
| Programming of multiple lead pacemaker system | 19 | $2,627 | $80 |
| Short return visit (20+ min) | 32 | $2,238 | $68 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,580 | $105 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 65 | $1,423 | $22 |
| 3d radiographic procedure | 53 | $1,348 | $25 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 54 | $1,314 | $23 |
| Programming of single lead pacemaker system | 14 | $1,036 | $65 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 46 | $959 | $21 |
| Measurement of heart blood flow and respiration | 29 | $853 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 54 | $729 | $13 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 46 | $591 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 65 | $590 | $9 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $423 | $17 |
2022: 40 services
| Return visit (30+ min) | 558 | $79,722 | $107 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 100 | $77,540 | $746 |
| Long return visit (40+ min) | 303 | $72,493 | $158 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 148 | $29,562 | $190 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 55 | $25,456 | $252 |
| New patient visit (60+ min) | 82 | $16,013 | $195 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 53 | $15,171 | $253 |
| Programming of dual lead pacemaker system | 103 | $14,862 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 207 | $9,606 | $22 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $8,275 | $436 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 157 | $7,469 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $7,048 | $93 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $6,820 | $568 |
| Programming of heart rhythm stimulation after drug infusion | 68 | $6,539 | $95 |
| New patient visit (45+ min) | 46 | $6,165 | $134 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $5,830 | $243 |
| External shock to heart to regulate heart beat | 44 | $5,664 | $99 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 60 | $5,243 | $23 |
| Return visit (30+ min) | 51 | $4,577 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,487 | $179 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 53 | $3,939 | $22 |
| Programming of dual lead implantable defibrillator system | 23 | $3,835 | $96 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 57 | $3,551 | $29 |
| Programming of multiple lead pacemaker system | 25 | $3,348 | $82 |
| Short return visit (20+ min) | 45 | $3,172 | $70 |
| Programming of multiple lead implantable defibrillator system | 16 | $3,059 | $102 |
| Evaluation of implantable heart and blood vessel monitoring system | 35 | $2,693 | $47 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 11 | $2,454 | $223 |
| 3d radiographic procedure | 72 | $1,743 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 67 | $1,550 | $22 |
| Programming of single lead pacemaker system | 16 | $1,365 | $65 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 50 | $1,298 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 53 | $1,271 | $24 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 48 | $1,036 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 52 | $777 | $15 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 48 | $710 | $14 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 67 | $620 | $9 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $608 | $51 |
| Heart muscle strain imaging | 11 | $515 | $40 |
| Measurement of heart blood flow and respiration | 12 | $269 | $22 |
2021: 46 services
| Return visit (30+ min) | 514 | $79,870 | $109 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 115 | $78,867 | $663 |
| Long return visit (40+ min) | 219 | $55,340 | $156 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 70 | $35,913 | $326 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 144 | $31,169 | $201 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 64 | $23,157 | $293 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 108 | $22,726 | $203 |
| New patient visit (60+ min) | 75 | $13,254 | $177 |
| Programming of dual lead pacemaker system | 81 | $11,844 | $76 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 184 | $11,704 | $24 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $11,435 | $457 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 107 | $8,884 | $80 |
| Programming of heart rhythm stimulation after drug infusion | 80 | $8,771 | $107 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 138 | $8,331 | $24 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $6,931 | $578 |
| New patient visit (45+ min) | 45 | $6,143 | $137 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $5,601 | $233 |
| External shock to heart to regulate heart beat | 46 | $5,233 | $101 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 53 | $5,210 | $23 |
| Removal and replacement of dual lead permanent pacemaker | 16 | $5,153 | $322 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,706 | $181 |
| Short return visit (20+ min) | 60 | $4,675 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,545 | $93 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 49 | $4,163 | $30 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 48 | $3,898 | $22 |
| Return visit (30+ min) | 40 | $3,638 | $91 |
| Evaluation of implantable heart and blood vessel monitoring system | 37 | $3,620 | $45 |
| Programming of dual lead implantable defibrillator system | 18 | $3,489 | $92 |
| Programming of multiple lead implantable defibrillator system | 15 | $3,288 | $100 |
| Programming of multiple lead pacemaker system | 22 | $2,905 | $81 |
| Programming of single lead pacemaker system | 18 | $1,973 | $66 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 60 | $1,438 | $23 |
| 3d radiographic procedure | 59 | $1,394 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 60 | $1,376 | $23 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,307 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 96 | $1,154 | $12 |
| Short return visit (20+ min) | 16 | $983 | $61 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 11 | $963 | $88 |
| 3d radiographic procedure with computerized image postprocessing | 13 | $925 | $71 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 38 | $909 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 59 | $888 | $15 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $744 | $62 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 30 | $678 | $22 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 60 | $599 | $10 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 30 | $468 | $15 |
| Heart muscle strain imaging | 11 | $463 | $42 |
2020: 39 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 100 | $73,826 | $724 |
| Return visit (30+ min) | 501 | $68,285 | $89 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 63 | $28,017 | $326 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 104 | $21,495 | $203 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 100 | $21,110 | $207 |
| Long return visit (40+ min) | 119 | $17,899 | $122 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 190 | $10,258 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 446 | $9,393 | $15 |
| New patient visit (60+ min) | 49 | $9,141 | $187 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $8,669 | $456 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 34 | $8,493 | $218 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 91 | $8,150 | $88 |
| Programming of heart rhythm stimulation after drug infusion | 72 | $7,934 | $109 |
| Programming of dual lead pacemaker system | 68 | $7,187 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $7,004 | $96 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 134 | $6,865 | $25 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 73 | $6,473 | $25 |
| New patient visit (45+ min) | 42 | $5,626 | $134 |
| Short return visit (20+ min) | 80 | $5,540 | $62 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 65 | $5,138 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 57 | $4,560 | $31 |
| External shock to heart to regulate heart beat | 35 | $4,224 | $103 |
| Telephone medical discussion with physician, 11-20 minutes | 61 | $4,004 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,206 | $189 |
| Telephone medical discussion with physician, 21-30 minutes | 28 | $3,201 | $103 |
| Evaluation of implantable heart and blood vessel monitoring system | 46 | $2,720 | $39 |
| External ekg recording for more than 48 hours up to 21 days | 91 | $2,532 | $27 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,377 | $198 |
| Programming of dual lead implantable defibrillator system | 19 | $2,341 | $84 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 91 | $2,273 | $24 |
| Programming of multiple lead implantable defibrillator system | 15 | $2,065 | $86 |
| Return visit (30+ min) | 28 | $1,952 | $70 |
| Anticoagulant management of patient taking warfarin | 11 | $1,798 | $10 |
| Programming of multiple lead pacemaker system | 17 | $1,682 | $73 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 55 | $1,426 | $23 |
| Programming of single lead pacemaker system | 15 | $1,186 | $54 |
| 3d radiographic procedure | 47 | $1,108 | $23 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 63 | $676 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 54 | $561 | $9 |
2019: 46 services
| Return visit (30+ min) | 535 | $82,800 | $91 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 101 | $63,493 | $616 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 120 | $25,829 | $203 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 102 | $19,180 | $184 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 48 | $16,394 | $335 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 575 | $15,423 | $15 |
| Long return visit (40+ min) | 97 | $15,133 | $130 |
| Short return visit (20+ min) | 191 | $11,972 | $54 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 27 | $11,864 | $439 |
| Programming of dual lead pacemaker system | 106 | $11,255 | $59 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $9,572 | $223 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $9,157 | $610 |
| New patient visit (60+ min) | 52 | $8,700 | $167 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 143 | $7,980 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $7,497 | $94 |
| New patient visit (45+ min) | 53 | $7,430 | $140 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 77 | $6,839 | $87 |
| Programming of heart rhythm stimulation after drug infusion | 57 | $6,614 | $114 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 58 | $5,335 | $37 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 54 | $5,071 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system | 59 | $5,015 | $35 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,923 | $182 |
| External shock to heart to regulate heart beat | 41 | $4,864 | $99 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 20 | $4,709 | $224 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 87 | $4,530 | $25 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 11 | $4,526 | $411 |
| Removal and replacement of dual lead permanent pacemaker | 14 | $4,460 | $319 |
| Programming of dual lead implantable defibrillator system | 22 | $4,169 | $76 |
| Programming of multiple lead implantable defibrillator system | 21 | $4,022 | $82 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 62 | $3,426 | $12 |
| Programming of multiple lead pacemaker system | 24 | $3,347 | $63 |
| Anticoagulant management of patient taking warfarin | 18 | $3,061 | $10 |
| 3d radiographic procedure | 98 | $2,329 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 41 | $2,294 | $55 |
| External ekg recording for more than 48 hours up to 21 days | 73 | $1,857 | $25 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 73 | $1,677 | $22 |
| Programming of single lead pacemaker system | 17 | $1,607 | $50 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 14 | $1,359 | $97 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $1,156 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $1,116 | $27 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 44 | $1,114 | $23 |
| New patient visit (30+ min) | 13 | $1,072 | $82 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 79 | $774 | $6 |
| Return visit (30+ min) | 11 | $748 | $68 |
| Short return visit (20+ min) | 11 | $507 | $46 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 44 | $454 | $10 |
2018: 46 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 106 | $81,348 | $733 |
| Return visit (30+ min) | 470 | $72,379 | $89 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 99 | $25,957 | $245 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 114 | $25,027 | $200 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 57 | $22,386 | $361 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 14 | $21,033 | $1,502 |
| Short return visit (20+ min) | 266 | $20,729 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 537 | $14,566 | $15 |
| Programming of dual lead pacemaker system | 109 | $11,119 | $51 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 14 | $10,718 | $383 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 42 | $10,095 | $229 |
| New patient visit (45+ min) | 71 | $9,869 | $139 |
| Programming of heart rhythm stimulation after drug infusion | 66 | $9,392 | $138 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 86 | $8,735 | $96 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $8,150 | $453 |
| Long return visit (40+ min) | 51 | $7,260 | $121 |
| External shock to heart to regulate heart beat | 61 | $6,882 | $98 |
| New patient visit (60+ min) | 36 | $6,584 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $6,300 | $93 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 131 | $6,201 | $25 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 59 | $5,905 | $44 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 15 | $5,192 | $346 |
| Removal and replacement of dual lead permanent pacemaker | 15 | $4,687 | $312 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 60 | $4,611 | $22 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,321 | $180 |
| Evaluation of implantable heart and blood vessel monitoring system | 65 | $4,191 | $30 |
| Programming of dual lead implantable defibrillator system | 27 | $3,988 | $66 |
| Programming of multiple lead implantable defibrillator system | 26 | $3,955 | $73 |
| Anticoagulant management of patient taking warfarin | 16 | $3,912 | $11 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 67 | $3,085 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 74 | $3,001 | $25 |
| Programming of multiple lead pacemaker system | 24 | $2,835 | $56 |
| Injection, regadenoson, 0.1 mg | 15 | $2,661 | None |
| Ultrasound of heart blood flow, valves and chambers | 39 | $2,241 | $55 |
| 3d radiographic procedure | 82 | $2,003 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 69 | $1,858 | $22 |
| External ekg recording for more than 48 hours up to 21 days | 63 | $1,723 | $26 |
| New patient visit (30+ min) | 18 | $1,519 | $84 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 62 | $1,514 | $23 |
| Programming of single lead pacemaker system | 17 | $1,434 | $42 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 42 | $1,179 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 16 | $1,090 | $68 |
| Return visit (30+ min) | 12 | $839 | $70 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 68 | $739 | $9 |
| Short return visit (20+ min) | 16 | $730 | $46 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 69 | $634 | $6 |
2017: 49 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 113 | $78,916 | $658 |
| Return visit (30+ min) | 458 | $71,268 | $89 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 26 | $38,352 | $1,475 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 104 | $31,231 | $281 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 111 | $27,640 | $228 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 43 | $17,673 | $361 |
| Short return visit (20+ min) | 233 | $16,900 | $57 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 35 | $15,704 | $449 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 26 | $11,805 | $231 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 417 | $11,255 | $15 |
| Programming of heart rhythm stimulation after drug infusion | 76 | $10,568 | $130 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 39 | $10,449 | $261 |
| Programming of dual lead pacemaker system | 108 | $10,412 | $50 |
| New patient visit (45+ min) | 71 | $9,580 | $135 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 19 | $9,478 | $499 |
| New patient visit (60+ min) | 48 | $8,291 | $173 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 82 | $8,177 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $7,998 | $93 |
| Long return visit (40+ min) | 53 | $7,742 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,493 | $180 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 59 | $6,118 | $51 |
| External shock to heart to regulate heart beat | 47 | $5,912 | $100 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 12 | $4,864 | $405 |
| Injection, regadenoson, 0.1 mg | 27 | $4,684 | None |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 97 | $4,004 | $23 |
| Programming of dual lead implantable defibrillator system | 22 | $3,879 | $73 |
| Programming of multiple lead implantable defibrillator system | 24 | $3,806 | $75 |
| Evaluation of implantable heart and blood vessel monitoring system | 55 | $2,891 | $26 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 47 | $2,699 | $21 |
| 3d radiographic procedure | 108 | $2,621 | $23 |
| Programming of multiple lead pacemaker system | 25 | $2,621 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 29 | $2,171 | $75 |
| External ekg recording for more than 48 hours up to 21 days | 75 | $2,146 | $27 |
| Ultrasound of heart blood flow, valves and chambers | 38 | $2,141 | $55 |
| Programming of single lead pacemaker system | 23 | $1,963 | $41 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 75 | $1,899 | $24 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 59 | $1,709 | $11 |
| 3d radiographic procedure with computerized image postprocessing | 23 | $1,588 | $69 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 19 | $1,517 | $80 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 53 | $1,297 | $22 |
| New patient visit (30+ min) | 17 | $1,258 | $74 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 39 | $1,213 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,160 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $1,045 | $27 |
| Return visit (30+ min) | 11 | $842 | $70 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 90 | $784 | $6 |
| Short return visit (20+ min) | 12 | $545 | $45 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 53 | $544 | $9 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 12 | $434 | $14 |
2016: 47 services
| Return visit (30+ min) | 400 | $57,882 | $85 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 88 | $51,611 | $567 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 23 | $33,519 | $1,457 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $24,894 | $226 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 80 | $19,716 | $238 |
| Short return visit (20+ min) | 236 | $18,563 | $60 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 34 | $15,346 | $451 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 36 | $13,251 | $358 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 22 | $9,966 | $227 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $9,805 | $90 |
| Programming of dual lead pacemaker system | 101 | $9,689 | $51 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 35 | $9,551 | $265 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 343 | $9,410 | $15 |
| Removal and replacement of dual lead permanent pacemaker | 30 | $9,262 | $309 |
| New patient visit (45+ min) | 56 | $7,408 | $132 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 58 | $7,387 | $54 |
| New patient visit (60+ min) | 41 | $7,260 | $177 |
| Long return visit (40+ min) | 57 | $6,887 | $104 |
| Programming of heart rhythm stimulation after drug infusion | 46 | $6,481 | $135 |
| External shock to heart to regulate heart beat | 46 | $5,682 | $109 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 67 | $5,559 | $77 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 14 | $5,526 | $395 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 105 | $5,182 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,126 | $177 |
| Injection, regadenoson, 0.1 mg | 24 | $4,061 | None |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 56 | $3,692 | $21 |
| Programming of multiple lead implantable defibrillator system | 29 | $3,680 | $80 |
| Programming of dual lead implantable defibrillator system | 27 | $3,355 | $68 |
| Evaluation of implantable heart and blood vessel monitoring system | 71 | $3,135 | $25 |
| 3d radiographic procedure with computerized image postprocessing | 45 | $3,124 | $68 |
| Programming of single lead pacemaker system | 28 | $2,508 | $45 |
| Programming of multiple lead pacemaker system | 25 | $2,432 | $57 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 66 | $2,224 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 35 | $1,959 | $54 |
| External ekg recording for more than 48 hours up to 21 days | 67 | $1,846 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 25 | $1,841 | $74 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 47 | $1,812 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $1,765 | $63 |
| 3d radiographic procedure | 73 | $1,680 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 68 | $1,632 | $23 |
| Return visit (30+ min) | 17 | $1,168 | $69 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 41 | $1,050 | $22 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,033 | $65 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 122 | $967 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 35 | $958 | $27 |
| Short return visit (20+ min) | 13 | $581 | $45 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 41 | $449 | $10 |
2015: 54 services
| Return visit (30+ min) | 458 | $75,607 | $95 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 28 | $47,139 | $1,521 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 76 | $42,647 | $561 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 68 | $32,732 | $481 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 110 | $31,027 | $244 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 64 | $15,751 | $246 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 28 | $14,455 | $237 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $14,166 | $98 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $12,746 | $283 |
| Insertion of implantable defibrillator system | 14 | $11,715 | $837 |
| Programming of dual lead pacemaker system | 102 | $11,341 | $56 |
| Long return visit (40+ min) | 71 | $11,135 | $136 |
| Short return visit (20+ min) | 137 | $10,336 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 326 | $9,731 | $17 |
| Removal and replacement of dual lead permanent pacemaker | 26 | $8,825 | $339 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 25 | $8,610 | $344 |
| New patient visit (60+ min) | 46 | $8,163 | $177 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 20 | $8,147 | $407 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,982 | $190 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 59 | $7,452 | $59 |
| New patient visit (45+ min) | 49 | $7,024 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $5,911 | $68 |
| 3d radiographic procedure with computerized image postprocessing | 81 | $5,815 | $65 |
| Programming of heart rhythm stimulation after drug infusion | 41 | $5,658 | $135 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 17 | $5,554 | $327 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 57 | $5,312 | $93 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 97 | $5,189 | $27 |
| Programming of multiple lead implantable defibrillator system | 37 | $5,172 | $86 |
| Injection, regadenoson, 0.1 mg | 28 | $5,068 | None |
| Critical care, first 30-74 minutes | 19 | $4,937 | $206 |
| External shock to heart to regulate heart beat | 30 | $3,982 | $117 |
| Removal and replacement of multiple lead permanent pacemaker | 11 | $3,936 | $358 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 45 | $3,895 | $24 |
| Programming of dual lead implantable defibrillator system | 22 | $3,541 | $77 |
| Evaluation of implantable heart and blood vessel monitoring system | 67 | $3,391 | $27 |
| Programming of multiple lead pacemaker system | 25 | $2,965 | $64 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 11 | $2,697 | $225 |
| Return visit (30+ min) | 36 | $2,651 | $74 |
| Ultrasound of heart blood flow, valves and chambers | 42 | $2,572 | $58 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 24 | $2,462 | $98 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 27 | $2,283 | $76 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 55 | $2,268 | $13 |
| Programming of single lead pacemaker system | 22 | $1,832 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 39 | $1,803 | $28 |
| New patient visit (30+ min) | 18 | $1,696 | $94 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 143 | $1,596 | $7 |
| External ekg recording for more than 48 hours up to 21 days | 49 | $1,504 | $29 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 49 | $1,293 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 42 | $1,266 | $29 |
| Hospital discharge day management, 30 minutes or less | 15 | $1,045 | $70 |
| 3d radiographic procedure | 34 | $896 | $24 |
| Short return visit (20+ min) | 14 | $669 | $48 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 24 | $627 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 24 | $267 | $10 |
2014: 48 services
| Return visit (30+ min) | 460 | $77,569 | $89 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 46 | $69,329 | $1,475 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 66 | $31,614 | $465 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 105 | $26,224 | $226 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 46 | $21,054 | $229 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $12,591 | $92 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 32 | $11,822 | $338 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 26 | $11,816 | $438 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 38 | $10,294 | $271 |
| Programming of dual lead pacemaker system | 94 | $9,805 | $53 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 24 | $9,785 | $362 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 317 | $9,205 | $15 |
| Long return visit (40+ min) | 65 | $9,133 | $123 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 12 | $8,448 | $704 |
| 3d radiographic procedure with computerized image postprocessing | 96 | $8,253 | $82 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 32 | $8,055 | $212 |
| Injection, regadenoson, 0.1 mg | 46 | $7,802 | None |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 31 | $7,721 | $249 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 58 | $7,193 | $55 |
| Removal and replacement of dual lead permanent pacemaker | 21 | $6,773 | $323 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $6,100 | $555 |
| New patient visit (45+ min) | 42 | $5,876 | $140 |
| Short return visit (20+ min) | 80 | $5,690 | $61 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 84 | $4,428 | $24 |
| Programming of heart rhythm stimulation after drug infusion | 30 | $4,404 | $138 |
| Removal and replacement of multiple lead defibrillator | 12 | $4,149 | $346 |
| Programming of multiple lead implantable defibrillator system | 27 | $4,088 | $82 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 54 | $4,003 | $71 |
| New patient visit (60+ min) | 23 | $3,982 | $173 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 48 | $3,878 | $22 |
| Programming of multiple lead pacemaker system | 24 | $3,725 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $3,526 | $64 |
| Programming of dual lead implantable defibrillator system | 21 | $3,518 | $69 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 46 | $3,462 | $74 |
| Critical care, first 30-74 minutes | 14 | $3,127 | $195 |
| External shock to heart to regulate heart beat | 23 | $2,571 | $107 |
| Evaluation of implantable heart and blood vessel monitoring system | 51 | $2,515 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,340 | $180 |
| Programming of single lead pacemaker system | 24 | $2,246 | $44 |
| Ultrasound of heart blood flow, valves and chambers | 38 | $2,035 | $54 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 48 | $2,015 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 26 | $1,265 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 37 | $994 | $27 |
| Hospital discharge day management, 30 minutes or less | 14 | $919 | $66 |
| Return visit (30+ min) | 12 | $840 | $65 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 79 | $659 | $6 |
| 3d radiographic procedure | 19 | $549 | $29 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 12 | $281 | $23 |
2013: 45 services
| Return visit (30+ min) | 459 | $79,124 | $91 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 45 | $55,669 | $1,210 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 117 | $22,903 | $185 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 50 | $22,382 | $439 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 27 | $21,859 | $781 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 45 | $21,146 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $15,833 | $90 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 29 | $13,061 | $450 |
| 3d radiographic procedure with computerized image postprocessing | 131 | $11,166 | $81 |
| Long return visit (40+ min) | 62 | $10,817 | $126 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 287 | $9,702 | $17 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $9,228 | $220 |
| Programming of dual lead pacemaker system | 86 | $8,954 | $52 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 66 | $8,352 | $52 |
| Injection, regadenoson, 0.1 mg | 47 | $8,101 | None |
| New patient visit (60+ min) | 41 | $7,095 | $173 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 19 | $7,023 | $334 |
| Removal and replacement of dual lead permanent pacemaker | 21 | $6,419 | $306 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 24 | $6,198 | $221 |
| Short return visit (20+ min) | 90 | $6,092 | $56 |
| Critical care, first 30-74 minutes | 23 | $5,908 | $191 |
| Programming of multiple lead implantable defibrillator system | 28 | $5,412 | $80 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 87 | $4,986 | $25 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $4,867 | $374 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 62 | $4,846 | $21 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 15 | $4,651 | $291 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $4,011 | $63 |
| Programming of dual lead implantable defibrillator system | 28 | $3,993 | $69 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 48 | $3,769 | $77 |
| Programming of multiple lead pacemaker system | 23 | $3,642 | $61 |
| Evaluation of implantable heart and blood vessel monitoring system | 62 | $3,466 | $25 |
| External shock to heart to regulate heart beat | 25 | $2,937 | $105 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 39 | $2,773 | $69 |
| New patient visit (45+ min) | 19 | $2,569 | $135 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 16 | $2,292 | $143 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,285 | $176 |
| Programming of single lead pacemaker system | 23 | $2,189 | $45 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 59 | $1,994 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 41 | $1,861 | $44 |
| Programming of heart rhythm stimulation after drug infusion | 17 | $1,799 | $106 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,043 | $95 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 93 | $986 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 21 | $898 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $858 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 27 | $610 | $22 |
Drugs they prescribed that Part D paid
$1,077,011
Pharmacies billed $1,077,011 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
3,447 generic and 839 brand-name prescriptions · $1,077,011 in drug cost · 15 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 526 | $643,605 | $1,224 |
| Xarelto | 76 | $107,006 | $1,408 |
| Entresto | 60 | $82,914 | $1,382 |
| Repatha Sureclick | 16 | $25,369 | $1,586 |
| Praluent | 21 | $23,882 | $1,137 |
See all 57 drugs
| Eliquis | 526 | $643,605 | $1,224 |
| Xarelto | 76 | $107,006 | $1,408 |
| Entresto | 60 | $82,914 | $1,382 |
| Repatha Sureclick | 16 | $25,369 | $1,586 |
| Praluent | 21 | $23,882 | $1,137 |
| Dofetilide | 79 | $23,537 | $298 |
| Multaq | 16 | $13,537 | $846 |
| Edarbi | 20 | $11,108 | $555 |
| Flecainide Acetate | 232 | $9,892 | $43 |
| Propafenone | 75 | $6,465 | $86 |
| Corlanor | 14 | $5,597 | $400 |
| Diltiazem 24hr Er (Cd) | 153 | $4,958 | $32 |
| Ranolazine Er | 28 | $4,197 | $150 |
| Metoprolol | 248 | $4,073 | $16 |
| Dabigatran Etexilate | 13 | $3,507 | $270 |
| Ezetimibe | 111 | $3,330 | $30 |
| Rosuvastatin | 203 | $3,198 | $16 |
| Carvedilol | 242 | $3,020 | $12 |
| Potassium Chloride | 52 | $2,399 | $46 |
| Propafenone Hcl Er | 19 | $2,330 | $123 |
| Telmisartan | 58 | $1,877 | $32 |
| Candesartan Cilexetil | 13 | $1,693 | $130 |
| Atorvastatin | 167 | $1,645 | $10 |
| Sotalol | 84 | $1,537 | $18 |
| Nebivolol | 22 | $1,510 | $69 |
| Celecoxib | 26 | $1,320 | $51 |
| Lisinopril | 98 | $1,261 | $13 |
| Torsemide | 86 | $1,174 | $14 |
| Valsartan | 35 | $1,128 | $32 |
| Losartan | 105 | $1,112 | $11 |
| Amlodipine Besylate | 190 | $1,038 | $5 |
| Olmesartan Medoxomil | 29 | $1,020 | $35 |
| Amiodarone | 24 | $981 | $41 |
| Furosemide | 116 | $924 | $8 |
| Spironolactone | 114 | $890 | $8 |
| Simvastatin | 64 | $857 | $13 |
| Sotalol Af | 21 | $733 | $35 |
| Pravastatin | 49 | $577 | $12 |
| Chlorthalidone | 39 | $561 | $14 |
| Digoxin | 23 | $516 | $22 |
| Irbesartan | 24 | $424 | $18 |
| Metoprolol | 61 | $417 | $7 |
| Spironolactone-Hctz | 11 | $409 | $37 |
| Ramipril | 18 | $384 | $21 |
| Losartan-Hydrochlorothiazide | 25 | $379 | $15 |
| Clopidogrel | 33 | $252 | $8 |
| Triamterene-Hydrochlorothiazid | 23 | $216 | $9 |
| Benazepril | 12 | $201 | $17 |
| Finasteride | 11 | $191 | $17 |
| Tamsulosin | 15 | $173 | $12 |
| Warfarin | 25 | $162 | $6 |
| Atenolol | 17 | $155 | $9 |
| Zolpidem | 19 | $109 | $6 |
| Hydrochlorothiazide | 54 | $80 | $1 |
| Clonidine | 15 | $58 | $4 |
| Allopurinol | 14 | $9 | $1 |
| Amoxicillin | 11 | $3 | $0 |
Year by year
| 2024 | 4,286 | 591 | None | 20% | $1,077,011 |
| 2023 | 4,072 | 571 | 0% (0) | None | $1,043,636 |
| 2022 | 3,968 | 547 | 0% (0) | None | $868,705 |
| 2021 | 3,866 | 512 | None | 22% | $831,783 |
| 2020 | 3,926 | 481 | 0% (0) | 24% | $846,470 |
| 2019 | 3,760 | 463 | None | 25% | $702,649 |
| 2018 | 3,695 | 435 | None | 25% | $628,491 |
| 2017 | 3,460 | 408 | None | 29% | $570,310 |
| 2016 | 3,386 | 379 | None | 34% | $500,874 |
| 2015 | 3,193 | 333 | None | 35% | $399,053 |
| 2014 | 3,071 | 312 | None | 37% | $366,878 |
| 2013 | 2,912 | 296 | None | 36% | $327,691 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 62 drugs
| Eliquis | 479 | $560,718 | $1,171 |
| Xarelto | 97 | $126,549 | $1,305 |
| Entresto | 42 | $65,889 | $1,569 |
| Jardiance | 19 | $25,712 | $1,353 |
| Praluent | 15 | $22,597 | $1,506 |
| Dofetilide | 53 | $18,604 | $351 |
| Edarbi | 22 | $15,651 | $711 |
| Flecainide Acetate | 258 | $15,635 | $61 |
| Repatha Sureclick | 11 | $15,515 | $1,410 |
| Pradaxa | 15 | $12,073 | $805 |
| Propafenone | 98 | $11,119 | $113 |
| Bystolic | 16 | $8,321 | $520 |
| Dabigatran Etexilate | 15 | $7,312 | $487 |
| Ezetimibe | 107 | $6,335 | $59 |
| Corlanor | 11 | $5,748 | $523 |
| Diltiazem 24hr Er (Cd) | 127 | $5,642 | $44 |
| Metoprolol | 199 | $4,597 | $23 |
| Ranolazine Er | 14 | $4,365 | $312 |
| Propafenone Hcl Er | 16 | $4,104 | $256 |
| Sotalol | 85 | $3,578 | $42 |
| Nebivolol | 23 | $3,345 | $145 |
| Telmisartan | 41 | $3,170 | $77 |
| Carvedilol | 195 | $3,117 | $16 |
| Rosuvastatin | 145 | $3,069 | $21 |
| Valsartan | 50 | $3,018 | $60 |
| Atorvastatin | 173 | $2,590 | $15 |
| Potassium Chloride | 61 | $2,540 | $42 |
| Torsemide | 80 | $1,573 | $20 |
| Olmesartan Medoxomil | 37 | $1,414 | $38 |
| Amlodipine Besylate | 173 | $1,357 | $8 |
| Losartan | 91 | $1,335 | $15 |
| Eplerenone | 14 | $1,261 | $90 |
| Spironolactone | 106 | $1,249 | $12 |
| Celecoxib | 17 | $1,231 | $72 |
| Pravastatin | 60 | $1,151 | $19 |
| Lisinopril | 88 | $1,148 | $13 |
| Diltiazem 24hr Er (Xr) | 16 | $1,000 | $62 |
| Digoxin | 25 | $944 | $38 |
| Simvastatin | 71 | $923 | $13 |
| Sotalol Af | 13 | $915 | $70 |
| Furosemide | 98 | $887 | $9 |
| Chlorthalidone | 33 | $814 | $25 |
| Amiodarone | 15 | $776 | $52 |
| Irbesartan | 20 | $637 | $32 |
| Cartia Xt | 16 | $617 | $39 |
| Clopidogrel | 34 | $490 | $14 |
| Verapamil Er | 13 | $432 | $33 |
| Losartan-Hydrochlorothiazide | 30 | $412 | $14 |
| Triamterene-Hydrochlorothiazid | 24 | $400 | $17 |
| Metoprolol | 65 | $397 | $6 |
| Spironolactone-Hctz | 11 | $385 | $35 |
| Atenolol | 17 | $365 | $21 |
| Zolpidem | 34 | $313 | $9 |
| Ramipril | 22 | $308 | $14 |
| Hydrochlorothiazide | 75 | $286 | $4 |
| Tamsulosin | 14 | $266 | $19 |
| Warfarin | 27 | $205 | $8 |
| Metolazone | 13 | $202 | $16 |
| Finasteride | 11 | $181 | $16 |
| Clonidine | 14 | $148 | $11 |
| Diazepam | 12 | $65 | $5 |
| Alprazolam | 11 | $54 | $5 |
2022: 61 drugs
| Eliquis | 373 | $402,794 | $1,080 |
| Xarelto | 101 | $121,731 | $1,205 |
| Pradaxa | 57 | $52,025 | $913 |
| Entresto | 29 | $48,219 | $1,663 |
| Jardiance | 14 | $20,597 | $1,471 |
| Multaq | 13 | $18,589 | $1,430 |
| Flecainide Acetate | 263 | $17,602 | $67 |
| Repatha Sureclick | 18 | $17,350 | $964 |
| Bystolic | 21 | $14,062 | $670 |
| Dofetilide | 42 | $12,819 | $305 |
| Edarbi | 15 | $12,562 | $837 |
| Praluent | 12 | $12,278 | $1,023 |
| Propafenone | 88 | $9,074 | $103 |
| Ezetimibe | 92 | $7,895 | $86 |
| Rosuvastatin | 135 | $6,015 | $45 |
| Ranolazine Er | 18 | $5,511 | $306 |
| Diltiazem 24hr Er (Cd) | 157 | $5,357 | $34 |
| Metoprolol | 259 | $5,346 | $21 |
| Vascepa | 11 | $3,811 | $346 |
| Propafenone Hcl Er | 16 | $3,545 | $222 |
| Carvedilol | 212 | $3,262 | $15 |
| Sotalol | 84 | $3,182 | $38 |
| Potassium Chloride | 49 | $2,867 | $59 |
| Valsartan | 31 | $2,830 | $91 |
| Atorvastatin | 178 | $2,185 | $12 |
| Torsemide | 113 | $2,033 | $18 |
| Spironolactone | 142 | $1,960 | $14 |
| Telmisartan | 24 | $1,903 | $79 |
| Digoxin | 31 | $1,671 | $54 |
| Nebivolol | 20 | $1,589 | $79 |
| Losartan | 90 | $1,375 | $15 |
| Olmesartan Medoxomil | 38 | $1,347 | $35 |
| Amlodipine Besylate | 154 | $1,233 | $8 |
| Simvastatin | 61 | $1,205 | $20 |
| Chlorthalidone | 29 | $1,044 | $36 |
| Candesartan Cilexetil | 18 | $1,004 | $56 |
| Amiodarone | 21 | $947 | $45 |
| Furosemide | 101 | $934 | $9 |
| Pravastatin | 49 | $879 | $18 |
| Sotalol Af | 26 | $694 | $27 |
| Lisinopril | 79 | $610 | $8 |
| Ramipril | 21 | $554 | $26 |
| Irbesartan | 19 | $537 | $28 |
| Clopidogrel | 35 | $474 | $14 |
| Triamterene-Hydrochlorothiazid | 27 | $397 | $15 |
| Verapamil Er | 11 | $375 | $34 |
| Diltiazem 24hr Er | 18 | $354 | $20 |
| Metoprolol | 50 | $352 | $7 |
| Losartan-Hydrochlorothiazide | 34 | $351 | $10 |
| Metolazone | 14 | $343 | $24 |
| Tamsulosin | 12 | $266 | $22 |
| Warfarin | 24 | $263 | $11 |
| Finasteride | 12 | $247 | $21 |
| Benazepril | 15 | $188 | $13 |
| Atenolol | 14 | $133 | $10 |
| Clonidine | 14 | $118 | $8 |
| Hydrochlorothiazide | 43 | $102 | $2 |
| Alprazolam | 13 | $59 | $5 |
| Zolpidem | 11 | $42 | $4 |
| Amoxicillin | 11 | $15 | $1 |
| Glipizide | 12 | $15 | $1 |
2021: 54 drugs
| Eliquis | 373 | $354,735 | $951 |
| Xarelto | 117 | $136,752 | $1,169 |
| Pradaxa | 57 | $55,032 | $965 |
| Entresto | 31 | $44,329 | $1,430 |
| Flecainide Acetate | 285 | $19,792 | $69 |
| Repatha Sureclick | 21 | $19,548 | $931 |
| Bystolic | 38 | $15,877 | $418 |
| Edarbi | 22 | $14,249 | $648 |
| Dofetilide | 55 | $13,544 | $246 |
| Propafenone | 80 | $9,802 | $123 |
| Propafenone Hcl Er | 15 | $7,892 | $526 |
| Ezetimibe | 84 | $6,371 | $76 |
| Ranolazine Er | 20 | $6,235 | $312 |
| Rosuvastatin | 103 | $6,222 | $60 |
| Metoprolol | 257 | $5,130 | $20 |
| Edarbyclor | 13 | $4,663 | $359 |
| Diltiazem 24hr Er (Cd) | 121 | $4,504 | $37 |
| Vascepa | 13 | $4,373 | $336 |
| Potassium Chloride | 66 | $4,064 | $62 |
| Sotalol | 114 | $4,038 | $35 |
| Valsartan | 41 | $3,959 | $97 |
| Telmisartan | 51 | $3,476 | $68 |
| Carvedilol | 200 | $3,159 | $16 |
| Atorvastatin | 137 | $2,232 | $16 |
| Olmesartan Medoxomil | 39 | $2,156 | $55 |
| Digoxin | 33 | $1,810 | $55 |
| Amlodipine Besylate | 166 | $1,615 | $10 |
| Sotalol Af | 23 | $1,523 | $66 |
| Spironolactone | 127 | $1,331 | $10 |
| Torsemide | 83 | $1,195 | $14 |
| Chlorthalidone | 24 | $1,063 | $44 |
| Simvastatin | 59 | $1,014 | $17 |
| Furosemide | 122 | $948 | $8 |
| Pravastatin | 46 | $814 | $18 |
| Losartan | 52 | $807 | $16 |
| Irbesartan | 26 | $726 | $28 |
| Losartan-Hydrochlorothiazide | 27 | $706 | $26 |
| Colchicine | 14 | $661 | $47 |
| Ramipril | 21 | $510 | $24 |
| Diltiazem 24hr Er | 20 | $489 | $24 |
| Clopidogrel | 29 | $482 | $17 |
| Metolazone | 19 | $469 | $25 |
| Lisinopril | 70 | $461 | $7 |
| Warfarin | 32 | $417 | $13 |
| Triamterene-Hydrochlorothiazid | 23 | $395 | $17 |
| Alprazolam | 12 | $376 | $31 |
| Finasteride | 14 | $355 | $25 |
| Amiodarone | 14 | $314 | $22 |
| Hydrochlorothiazide | 56 | $224 | $4 |
| Metoprolol | 31 | $167 | $5 |
| Clonidine | 12 | $99 | $8 |
| Atenolol | 11 | $92 | $8 |
| Gemfibrozil | 11 | $60 | $5 |
| Glipizide | 13 | $15 | $1 |
2020: 53 drugs
| Eliquis | 376 | $332,810 | $885 |
| Xarelto | 134 | $133,952 | $1,000 |
| Pradaxa | 70 | $56,963 | $814 |
| Entresto | 44 | $50,613 | $1,150 |
| Flecainide Acetate | 216 | $20,908 | $97 |
| Dofetilide | 64 | $19,874 | $311 |
| Bystolic | 54 | $19,184 | $355 |
| Edarbi | 32 | $16,214 | $507 |
| Propafenone | 89 | $14,239 | $160 |
| Praluent | 13 | $11,940 | $918 |
| Ranolazine Er | 19 | $8,646 | $455 |
| Propafenone Hcl Er | 18 | $8,035 | $446 |
| Ezetimibe | 79 | $7,466 | $95 |
| Rosuvastatin | 80 | $5,882 | $74 |
| Valsartan | 50 | $5,609 | $112 |
| Metoprolol | 246 | $5,380 | $22 |
| Telmisartan | 67 | $4,969 | $74 |
| Sotalol | 130 | $4,387 | $34 |
| Diltiazem 24hr Er (Cd) | 78 | $4,327 | $55 |
| Potassium Chloride | 71 | $3,971 | $56 |
| Carvedilol | 225 | $2,947 | $13 |
| Atorvastatin | 152 | $2,639 | $17 |
| Losartan-Hydrochlorothiazide | 29 | $1,887 | $65 |
| Olmesartan Medoxomil | 31 | $1,862 | $60 |
| Torsemide | 98 | $1,829 | $19 |
| Cartia Xt | 24 | $1,556 | $65 |
| Digoxin | 24 | $1,491 | $62 |
| Spironolactone | 129 | $1,373 | $11 |
| Chlorthalidone | 22 | $1,291 | $59 |
| Amlodipine Besylate | 183 | $1,255 | $7 |
| Diltiazem 24hr Er | 27 | $1,145 | $42 |
| Pravastatin | 41 | $1,091 | $27 |
| Furosemide | 122 | $1,077 | $9 |
| Simvastatin | 72 | $1,052 | $15 |
| Irbesartan | 22 | $851 | $39 |
| Losartan | 44 | $745 | $17 |
| Lisinopril | 60 | $513 | $9 |
| Warfarin | 30 | $488 | $16 |
| Finasteride | 15 | $451 | $30 |
| Sotalol Af | 16 | $383 | $24 |
| Alprazolam | 18 | $353 | $20 |
| Metoprolol | 47 | $329 | $7 |
| Ramipril | 23 | $324 | $14 |
| Triamterene-Hydrochlorothiazid | 19 | $306 | $16 |
| Clopidogrel | 27 | $305 | $11 |
| Escitalopram | 15 | $244 | $16 |
| Tamsulosin | 11 | $234 | $21 |
| Hydrochlorothiazide | 43 | $169 | $4 |
| Meloxicam | 14 | $126 | $9 |
| Metformin Hcl Er | 18 | $98 | $5 |
| Gemfibrozil | 12 | $86 | $7 |
| Clonidine | 13 | $70 | $5 |
| Lovastatin | 12 | $29 | $2 |
2019: 59 drugs
| Eliquis | 328 | $242,053 | $738 |
| Xarelto | 136 | $119,850 | $881 |
| Entresto | 74 | $54,714 | $739 |
| Pradaxa | 55 | $34,788 | $633 |
| Dofetilide | 63 | $34,529 | $548 |
| Bystolic | 72 | $20,660 | $287 |
| Flecainide Acetate | 188 | $15,048 | $80 |
| Propafenone | 101 | $14,792 | $146 |
| Propafenone Hcl Er | 27 | $14,129 | $523 |
| Ranexa | 13 | $10,353 | $796 |
| Rythmol Sr | 12 | $8,836 | $736 |
| Edarbi | 17 | $8,023 | $472 |
| Ezetimibe | 87 | $6,816 | $78 |
| Metoprolol | 199 | $6,129 | $31 |
| Ranolazine Er | 13 | $5,816 | $447 |
| Rosuvastatin | 54 | $5,310 | $98 |
| Sotalol | 105 | $4,259 | $41 |
| Potassium Chloride | 56 | $3,231 | $58 |
| Carvedilol | 210 | $3,225 | $15 |
| Diltiazem 24hr Er (Cd) | 74 | $3,018 | $41 |
| Atorvastatin | 134 | $2,926 | $22 |
| Corlanor | 11 | $2,607 | $237 |
| Telmisartan | 50 | $2,471 | $49 |
| Torsemide | 122 | $2,334 | $19 |
| Valsartan | 38 | $2,100 | $55 |
| Spironolactone | 159 | $1,591 | $10 |
| Cartia Xt | 29 | $1,529 | $53 |
| Chlorthalidone | 24 | $1,476 | $61 |
| Digoxin | 28 | $1,359 | $49 |
| Pravastatin | 40 | $1,281 | $32 |
| Simvastatin | 84 | $1,218 | $14 |
| Furosemide | 119 | $1,098 | $9 |
| Amlodipine Besylate | 160 | $1,095 | $7 |
| Irbesartan | 23 | $971 | $42 |
| Diltiazem 24hr Er | 18 | $872 | $48 |
| Midodrine | 19 | $822 | $43 |
| Dilt-Xr | 12 | $818 | $68 |
| Lisinopril | 73 | $759 | $10 |
| Amlodipine-Valsartan | 11 | $688 | $63 |
| Warfarin | 35 | $621 | $18 |
| Losartan | 43 | $554 | $13 |
| Olmesartan Medoxomil | 15 | $533 | $36 |
| Finasteride | 16 | $531 | $33 |
| Metoprolol | 47 | $528 | $11 |
| Escitalopram | 13 | $460 | $35 |
| Sotalol Af | 11 | $451 | $41 |
| Triamterene-Hydrochlorothiazid | 26 | $382 | $15 |
| Clopidogrel | 30 | $351 | $12 |
| Ramipril | 23 | $326 | $14 |
| Losartan-Hydrochlorothiazide | 28 | $253 | $9 |
| Atenolol | 20 | $227 | $11 |
| Tamsulosin | 13 | $215 | $17 |
| Alprazolam | 14 | $210 | $15 |
| Metformin Hcl Er | 19 | $157 | $8 |
| Gemfibrozil | 12 | $150 | $13 |
| Meloxicam | 15 | $139 | $9 |
| Clonidine | 15 | $137 | $9 |
| Hydrochlorothiazide | 30 | $89 | $3 |
| Lovastatin | 12 | $25 | $2 |
2018: 55 drugs
| Eliquis | 308 | $195,201 | $634 |
| Xarelto | 128 | $109,304 | $854 |
| Dofetilide | 61 | $41,108 | $674 |
| Pradaxa | 62 | $37,887 | $611 |
| Ranexa | 23 | $23,392 | $1,017 |
| Bystolic | 94 | $19,875 | $211 |
| Entresto | 21 | $18,289 | $871 |
| Propafenone Hcl Er | 44 | $15,819 | $360 |
| Propafenone | 118 | $12,674 | $107 |
| Flecainide Acetate | 165 | $10,900 | $66 |
| Multaq | 15 | $10,621 | $708 |
| Rythmol Sr | 12 | $9,257 | $771 |
| Edarbi | 25 | $8,134 | $325 |
| Metoprolol | 246 | $7,053 | $29 |
| Edarbyclor | 15 | $6,853 | $457 |
| Ezetimibe | 63 | $6,647 | $106 |
| Potassium Chloride | 75 | $5,039 | $67 |
| Rosuvastatin | 45 | $3,836 | $85 |
| Carvedilol | 236 | $3,104 | $13 |
| Sotalol | 72 | $2,975 | $41 |
| Digoxin | 57 | $2,944 | $52 |
| Atorvastatin | 128 | $2,944 | $23 |
| Cartia Xt | 61 | $2,230 | $37 |
| Torsemide | 104 | $2,220 | $21 |
| Valsartan | 34 | $1,939 | $57 |
| Diltiazem 24hr Er (Cd) | 66 | $1,928 | $29 |
| Pravastatin | 43 | $1,680 | $39 |
| Olmesartan Medoxomil | 20 | $1,646 | $82 |
| Simvastatin | 69 | $1,075 | $16 |
| Spironolactone | 100 | $1,044 | $10 |
| Chlorthalidone | 21 | $1,042 | $50 |
| Amlodipine Besylate | 144 | $1,023 | $7 |
| Furosemide | 109 | $980 | $9 |
| Warfarin | 38 | $911 | $24 |
| Amlodipine-Valsartan | 12 | $835 | $70 |
| Dilt-Xr | 17 | $833 | $49 |
| Digox | 13 | $813 | $63 |
| Clopidogrel | 31 | $791 | $26 |
| Diltiazem 24hr Er | 16 | $778 | $49 |
| Lisinopril | 78 | $734 | $9 |
| Irbesartan | 22 | $652 | $30 |
| Losartan | 62 | $649 | $10 |
| Telmisartan | 11 | $611 | $56 |
| Metoprolol | 62 | $539 | $9 |
| Tamsulosin | 13 | $538 | $41 |
| Escitalopram | 17 | $514 | $30 |
| Metolazone | 12 | $403 | $34 |
| Midodrine | 12 | $390 | $32 |
| Triamterene-Hydrochlorothiazid | 23 | $345 | $15 |
| Alprazolam | 18 | $266 | $15 |
| Zolpidem | 22 | $238 | $11 |
| Losartan-Hydrochlorothiazide | 15 | $207 | $14 |
| Ramipril | 21 | $189 | $9 |
| Atenolol | 18 | $117 | $7 |
| Hydrochlorothiazide | 34 | $78 | $2 |
2017: 57 drugs
| Eliquis | 218 | $120,468 | $553 |
| Xarelto | 143 | $103,227 | $722 |
| Dofetilide | 84 | $43,208 | $514 |
| Pradaxa | 58 | $40,003 | $690 |
| Propafenone Hcl Er | 51 | $24,628 | $483 |
| Ranexa | 26 | $19,091 | $734 |
| Bystolic | 77 | $18,160 | $236 |
| Propafenone | 112 | $12,247 | $109 |
| Edarbi | 30 | $11,135 | $371 |
| Multaq | 18 | $10,489 | $583 |
| Zetia | 13 | $9,842 | $757 |
| Ezetimibe | 31 | $9,283 | $299 |
| Flecainide Acetate | 111 | $7,715 | $70 |
| Metoprolol | 207 | $6,502 | $31 |
| Lanoxin | 14 | $5,435 | $388 |
| Rosuvastatin | 43 | $4,737 | $110 |
| Potassium Chloride | 70 | $3,578 | $51 |
| Digoxin | 65 | $3,222 | $50 |
| Valsartan | 51 | $3,184 | $62 |
| Atorvastatin | 131 | $2,629 | $20 |
| Carvedilol | 222 | $2,361 | $11 |
| Eplerenone | 16 | $2,282 | $143 |
| Torsemide | 77 | $1,858 | $24 |
| Olmesartan Medoxomil | 16 | $1,841 | $115 |
| Diltiazem 24hr Er | 59 | $1,833 | $31 |
| Sotalol | 70 | $1,716 | $25 |
| Cartia Xt | 46 | $1,524 | $33 |
| Digox | 19 | $1,456 | $77 |
| Warfarin | 41 | $1,286 | $31 |
| Midodrine | 25 | $1,172 | $47 |
| Pravastatin | 31 | $1,117 | $36 |
| Dilt-Xr | 20 | $1,046 | $52 |
| Chlorthalidone | 19 | $1,014 | $53 |
| Klor-Con Sprinkle | 17 | $901 | $53 |
| Simvastatin | 63 | $860 | $14 |
| Spironolactone | 66 | $838 | $13 |
| Furosemide | 103 | $804 | $8 |
| Tamsulosin | 26 | $751 | $29 |
| Amlodipine-Valsartan | 11 | $699 | $64 |
| Valsartan-Hydrochlorothiazide | 18 | $644 | $36 |
| Amlodipine Besylate | 101 | $635 | $6 |
| Metoprolol | 106 | $616 | $6 |
| Losartan | 63 | $598 | $9 |
| Lisinopril | 52 | $559 | $11 |
| Clopidogrel | 34 | $463 | $14 |
| Escitalopram | 12 | $397 | $33 |
| Diltiazem 24hr Cd | 18 | $381 | $21 |
| Metolazone | 11 | $381 | $35 |
| Zolpidem | 26 | $306 | $12 |
| Losartan-Hydrochlorothiazide | 16 | $257 | $16 |
| Alprazolam | 16 | $252 | $16 |
| Amiodarone | 21 | $226 | $11 |
| Triamterene-Hydrochlorothiazid | 18 | $222 | $12 |
| Montelukast | 11 | $213 | $19 |
| Meloxicam | 11 | $165 | $15 |
| Ramipril | 16 | $141 | $9 |
| Hydrochlorothiazide | 27 | $71 | $3 |
2016: 60 drugs
| Eliquis | 183 | $85,586 | $468 |
| Xarelto | 117 | $75,068 | $642 |
| Pradaxa | 77 | $42,759 | $555 |
| Propafenone Hcl Er | 60 | $24,983 | $416 |
| Zetia | 39 | $19,595 | $502 |
| Tikosyn | 24 | $19,028 | $793 |
| Dofetilide | 34 | $14,637 | $431 |
| Bystolic | 71 | $14,452 | $204 |
| Vytorin | 19 | $13,548 | $713 |
| Crestor | 19 | $11,556 | $608 |
| Multaq | 21 | $10,702 | $510 |
| Effient | 14 | $8,526 | $609 |
| Edarbi | 23 | $8,281 | $360 |
| Metoprolol | 252 | $8,188 | $32 |
| Ranexa | 16 | $7,422 | $464 |
| Azor | 15 | $7,110 | $474 |
| Benicar | 16 | $6,971 | $436 |
| Lanoxin | 19 | $5,296 | $279 |
| Propafenone | 66 | $4,756 | $72 |
| Flecainide Acetate | 101 | $4,052 | $40 |
| Potassium Chloride | 62 | $3,754 | $61 |
| Digoxin | 70 | $3,678 | $53 |
| Eplerenone | 26 | $3,612 | $139 |
| Valsartan | 31 | $2,987 | $96 |
| Atorvastatin | 144 | $2,867 | $20 |
| Rosuvastatin | 12 | $2,573 | $214 |
| Carvedilol | 213 | $2,386 | $11 |
| Diltiazem 24hr Er | 56 | $1,769 | $32 |
| Sotalol | 64 | $1,486 | $23 |
| Digox | 28 | $1,266 | $45 |
| Chlorthalidone | 27 | $1,167 | $43 |
| Fenofibrate | 13 | $1,132 | $87 |
| Torsemide | 52 | $1,095 | $21 |
| Pravastatin | 37 | $1,081 | $29 |
| Midodrine | 19 | $1,051 | $55 |
| Spironolactone | 72 | $979 | $14 |
| Dilt-Xr | 17 | $952 | $56 |
| Cartia Xt | 33 | $936 | $28 |
| Amlodipine Besylate | 111 | $930 | $8 |
| Simvastatin | 65 | $888 | $14 |
| Furosemide | 149 | $830 | $6 |
| Warfarin | 38 | $707 | $19 |
| Mexiletine | 12 | $560 | $47 |
| Losartan | 65 | $520 | $8 |
| Isosorbide Mononitrate Er | 23 | $516 | $22 |
| Escitalopram | 21 | $509 | $24 |
| Metoprolol | 74 | $500 | $7 |
| Diltiazem Er | 16 | $408 | $25 |
| Lisinopril | 64 | $373 | $6 |
| Tamsulosin | 11 | $356 | $32 |
| Alprazolam | 30 | $321 | $11 |
| Zolpidem | 28 | $317 | $11 |
| Clopidogrel | 31 | $316 | $10 |
| Levothyroxine | 14 | $303 | $22 |
| Diltiazem 24hr Cd | 11 | $271 | $25 |
| Losartan-Hydrochlorothiazide | 20 | $267 | $13 |
| Valsartan-Hydrochlorothiazide | 17 | $264 | $16 |
| Triamterene-Hydrochlorothiazid | 18 | $226 | $13 |
| Ramipril | 14 | $217 | $15 |
| Hydrochlorothiazide | 19 | $64 | $3 |
2015: 60 drugs
| Xarelto | 135 | $71,445 | $529 |
| Pradaxa | 70 | $32,820 | $469 |
| Tikosyn | 71 | $31,968 | $450 |
| Eliquis | 58 | $29,512 | $509 |
| Propafenone Hcl Er | 53 | $27,615 | $521 |
| Zetia | 44 | $18,431 | $419 |
| Bystolic | 67 | $14,049 | $210 |
| Crestor | 26 | $11,692 | $450 |
| Vytorin | 13 | $8,154 | $627 |
| Benicar | 17 | $6,700 | $394 |
| Ranexa | 13 | $6,642 | $511 |
| Benicar Hct | 18 | $6,361 | $353 |
| Metoprolol | 190 | $6,034 | $32 |
| Edarbi | 34 | $5,566 | $164 |
| Valsartan | 39 | $5,340 | $137 |
| Propafenone | 71 | $5,006 | $71 |
| Azor | 24 | $4,936 | $206 |
| Flecainide Acetate | 109 | $4,410 | $40 |
| Eplerenone | 25 | $4,301 | $172 |
| Digoxin | 79 | $3,902 | $49 |
| Coreg Cr | 11 | $3,872 | $352 |
| Potassium Chloride | 74 | $3,855 | $52 |
| Edarbyclor | 14 | $3,096 | $221 |
| Atorvastatin | 159 | $2,737 | $17 |
| Fenofibrate | 17 | $2,014 | $118 |
| Carvedilol | 227 | $1,929 | $8 |
| Lanoxin | 16 | $1,868 | $117 |
| Digox | 27 | $1,596 | $59 |
| Diltiazem Er | 38 | $1,451 | $38 |
| Sotalol | 89 | $1,325 | $15 |
| Torsemide | 58 | $1,319 | $23 |
| Pravastatin | 31 | $1,265 | $41 |
| Diltiazem 24hr Er | 42 | $1,218 | $29 |
| Cartia Xt | 60 | $1,174 | $20 |
| Mexiletine | 13 | $1,129 | $87 |
| Amlodipine Besylate | 124 | $1,039 | $8 |
| Warfarin | 49 | $819 | $17 |
| Synthroid | 15 | $761 | $51 |
| Chlorthalidone | 13 | $743 | $57 |
| Midodrine | 16 | $720 | $45 |
| Simvastatin | 62 | $622 | $10 |
| Triamterene-Hydrochlorothiazid | 20 | $621 | $31 |
| Spironolactone | 55 | $593 | $11 |
| Clopidogrel | 22 | $569 | $26 |
| Furosemide | 110 | $518 | $5 |
| Metolazone | 16 | $503 | $31 |
| Losartan | 44 | $490 | $11 |
| Toprol Xl | 11 | $391 | $36 |
| Dilt-Xr | 12 | $381 | $32 |
| Escitalopram | 18 | $358 | $20 |
| Losartan-Hydrochlorothiazide | 20 | $345 | $17 |
| Isosorbide Mononitrate Er | 29 | $313 | $11 |
| Lisinopril | 47 | $312 | $7 |
| Isosorbide Dinitrate | 12 | $306 | $25 |
| Metoprolol | 49 | $268 | $5 |
| Zolpidem | 28 | $239 | $9 |
| Alprazolam | 18 | $180 | $10 |
| Amiodarone | 11 | $97 | $9 |
| Pantoprazole | 11 | $83 | $8 |
| Hydrochlorothiazide | 11 | $32 | $3 |
2014: 58 drugs
| Xarelto | 155 | $63,684 | $411 |
| Pradaxa | 114 | $47,336 | $415 |
| Tikosyn | 75 | $30,071 | $401 |
| Propafenone Hcl Er | 38 | $22,870 | $602 |
| Zetia | 35 | $13,142 | $375 |
| Eliquis | 32 | $11,848 | $370 |
| Bystolic | 73 | $10,355 | $142 |
| Vytorin | 17 | $8,707 | $512 |
| Diovan | 26 | $7,764 | $299 |
| Crestor | 25 | $6,793 | $272 |
| Ranexa | 13 | $6,698 | $515 |
| Metoprolol | 174 | $6,661 | $38 |
| Propafenone | 65 | $6,369 | $98 |
| Benicar | 23 | $6,153 | $268 |
| Exforge | 15 | $5,312 | $354 |
| Benicar Hct | 17 | $4,763 | $280 |
| Eplerenone | 27 | $3,846 | $142 |
| Digox | 83 | $3,706 | $45 |
| Flecainide Acetate | 82 | $3,704 | $45 |
| Potassium Chloride | 61 | $3,700 | $61 |
| Azor | 23 | $3,392 | $147 |
| Digoxin | 59 | $2,995 | $51 |
| Atorvastatin | 159 | $2,910 | $18 |
| Nexium | 11 | $2,682 | $244 |
| Carvedilol | 207 | $2,546 | $12 |
| Pravastatin | 56 | $2,040 | $36 |
| Edarbi | 17 | $2,029 | $119 |
| Sotalol | 88 | $1,981 | $23 |
| Fenofibrate | 13 | $1,971 | $152 |
| Diltiazem 24hr Er | 71 | $1,709 | $24 |
| Clopidogrel | 29 | $1,262 | $44 |
| Lanoxin | 15 | $1,125 | $75 |
| Torsemide | 43 | $1,120 | $26 |
| Amlodipine Besylate | 92 | $1,078 | $12 |
| Diltiazem Er | 25 | $1,078 | $43 |
| Mexiletine | 13 | $975 | $75 |
| Toprol Xl | 14 | $971 | $69 |
| Simvastatin | 64 | $887 | $14 |
| Warfarin | 75 | $803 | $11 |
| Synthroid | 17 | $743 | $44 |
| Losartan-Hydrochlorothiazide | 27 | $672 | $25 |
| Diltiazem 24hr Cd | 23 | $638 | $28 |
| Midodrine | 13 | $530 | $41 |
| Losartan | 69 | $514 | $7 |
| Triamterene-Hydrochlorothiazid | 20 | $507 | $25 |
| Chlorthalidone | 19 | $505 | $27 |
| Isosorbide Mononitrate Er | 25 | $476 | $19 |
| Escitalopram | 21 | $467 | $22 |
| Cartia Xt | 14 | $434 | $31 |
| Spironolactone | 33 | $417 | $13 |
| Lisinopril | 28 | $352 | $13 |
| Metoprolol | 60 | $288 | $5 |
| Furosemide | 75 | $258 | $3 |
| Zolpidem | 18 | $206 | $11 |
| Ramipril | 11 | $187 | $17 |
| Benazepril | 15 | $185 | $12 |
| Alprazolam | 18 | $116 | $6 |
| Terazosin | 13 | $101 | $8 |
2013: 53 drugs
| Xarelto | 133 | $49,617 | $373 |
| Pradaxa | 137 | $48,102 | $351 |
| Tikosyn | 81 | $30,597 | $378 |
| Propafenone | 109 | $24,185 | $222 |
| Zetia | 50 | $14,820 | $296 |
| Vytorin | 21 | $8,952 | $426 |
| Diovan | 38 | $8,925 | $235 |
| Benicar | 44 | $8,394 | $191 |
| Crestor | 36 | $8,380 | $233 |
| Metoprolol | 154 | $6,753 | $44 |
| Ranexa | 18 | $4,662 | $259 |
| Bystolic | 35 | $4,602 | $131 |
| Lipitor | 15 | $4,430 | $295 |
| Eliquis | 16 | $4,328 | $271 |
| Eplerenone | 25 | $4,245 | $170 |
| Atorvastatin | 122 | $3,633 | $30 |
| Welchol | 11 | $3,399 | $309 |
| Flecainide Acetate | 61 | $2,790 | $46 |
| Potassium Chloride | 59 | $2,690 | $46 |
| Carvedilol | 144 | $2,568 | $18 |
| Diltiazem Er | 53 | $2,400 | $45 |
| Fenofibrate | 14 | $2,292 | $164 |
| Sotalol | 60 | $2,245 | $37 |
| Diltiazem 24hr Er | 58 | $1,528 | $26 |
| Edarbi | 14 | $1,334 | $95 |
| Amlodipine Besylate | 88 | $1,291 | $15 |
| Toprol Xl | 14 | $1,283 | $92 |
| Torsemide | 48 | $1,124 | $23 |
| Clopidogrel | 23 | $1,123 | $49 |
| Mexiletine | 20 | $1,052 | $53 |
| Pravastatin | 62 | $999 | $16 |
| Losartan-Hydrochlorothiazide | 17 | $927 | $55 |
| Simvastatin | 57 | $915 | $16 |
| Digox | 81 | $846 | $10 |
| Escitalopram | 26 | $788 | $30 |
| Cartia Xt | 17 | $758 | $45 |
| Losartan | 70 | $739 | $11 |
| Warfarin | 70 | $694 | $10 |
| Chlorthalidone | 33 | $520 | $16 |
| Synthroid | 15 | $507 | $34 |
| Metoprolol | 74 | $464 | $6 |
| Triamterene-Hctz | 28 | $450 | $16 |
| Lisinopril | 36 | $390 | $11 |
| Spironolactone | 33 | $377 | $11 |
| Isosorbide Mononitrate Er | 27 | $348 | $13 |
| Digoxin | 36 | $327 | $9 |
| Furosemide | 62 | $313 | $5 |
| Amiodarone | 21 | $301 | $14 |
| Terazosin | 23 | $207 | $9 |
| Zolpidem | 26 | $178 | $7 |
| Benazepril | 16 | $172 | $11 |
| Alprazolam | 20 | $134 | $7 |
| Atenolol | 20 | $89 | $4 |
Money from drug and device companies
$6,424 in 2025
| 2025 | 3 | 15 | $4,550 | $6,424 |
| 2024 | 5 | 24 | $33,750 | $35,877 |
| 2023 | 6 | 19 | $28,938 | $29,813 |
| 2022 | 6 | 13 | $25,925 | $26,507 |
| 2021 | 3 | 13 | $22,525 | $22,646 |
| 2020 | 8 | 30 | $33,000 | $33,454 |
| 2019 | 18 | 120 | $25,097 | $29,032 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | None | $5,742 | 8 payments
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $539 | 6 payments
|
| Biosense Webster | Carto 3 | $144 | 1 payment
|
See all 15 published payments
| Medtronic | Consulting · 2025-10-02 | None | $4,150 |
| Medtronic | Travel · 2025-09-29 | None | $490 |
| Medtronic | Meals · 2025-09-23 | None | $39 |
| Medtronic | Meals · 2025-09-23 | None | $45 |
| Medtronic | Meals · 2025-09-23 | None | $9 |
| AtriCure | Meals · 2025-09-18 | Synergy Ablation System | $186 |
| Medtronic | Consulting · 2025-09-04 | None | $400 |
| Medtronic | Travel · 2025-08-05 | None | $303 |
| Medtronic | Travel · 2025-08-05 | None | $305 |
| Biosense Webster | Meals · 2025-07-30 | Carto 3 | $144 |
| AtriCure | Meals · 2025-07-23 | Epi-Sense Guided Coagulation System With Visitrax | $164 |
| AtriCure | Meals · 2025-07-17 | Epi-Sense Guided Coagulation System With Visitrax | $37 |
| AtriCure | Meals · 2025-05-27 | Epi-Sense Guided Coagulation System With Visitrax | $106 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $36 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $11 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $35,877
| iRhythm Technologies | Zio Xt Patch | $28,800 | 8 payments
|
| Medtronic | None | $6,460 | 12 payments
|
| Boston Scientific | Rhythmia Mapping System | $282 | 2 payments
|
| Impulse Dynamics (USA) | Optimizer | $185 | 1 payment
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $149 | 1 payment
|
2023: $29,813
| iRhythm Technologies | Zio Xt Patch | $26,497 | 9 payments
|
| Medtronic | Micra | $2,634 | 6 payments
|
| Ablacon | None | $241 | 1 payment
|
| Abbott Laboratories | Tacticath Ablation Catheter, Sensor Enabled | $170 | 1 payment
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $150 | 1 payment
|
| Biosense Webster | Carto 3 | $121 | 1 payment
|
2022: $26,507
| iRhythm Technologies | Zio Xt Patch | $24,000 | 5 payments
|
| Medtronic | None | $1,925 | 3 payments
|
| Abbott Laboratories | Ensite Precision | $212 | 1 payment
|
| Boston Scientific | Rhythmia Mapping System | $153 | 2 payments
|
| Biosense Webster | Carto 3 | $115 | 1 payment
|
| Stryker | Cinchlock | $102 | 1 payment
|
2021: $22,646
| iRhythm Technologies | Zio Patch | $19,200 | 8 payments
|
| Medtronic | None | $3,325 | 4 payments
|
| Biosense Webster | Carto 3 | $121 | 1 payment
|
2020: $33,454
| iRhythm Technologies | Zio Patch | $28,800 | 12 payments
|
| Medtronic Vascular | Reveal Linq | $4,215 | 7 payments
|
| Medicure Pharma | Heart Failure Device. | $228 | 1 payment
|
| Pfizer | Eliquis | $99 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $40 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $30 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $21 | 1 payment
|
2019: $29,032
| iRhythm Technologies | Zio Patch | $19,385 | 6 payments
|
| Medtronic Vascular | Azure | $6,812 | 18 payments
|
| Medical Device Business Services | Carto 3 System | $1,131 | 13 payments
|
| Janssen Pharmaceuticals | Xarelto | $394 | 28 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $221 | 19 payments
|
| Stryker | Cinchlock Ss | $179 | 3 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $164 | 2 payments
|
| Biosense Webster | Carto Smarttouch | $125 | 2 payments
|
| Amgen | Repatha | $122 | 4 payments
|
| Pfizer | Eliquis | $98 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $83 | 4 payments
|
| Sanofi-Aventis U.S. | Praluent | $75 | 4 payments
|
| Arbor Pharmaceuticals | Edarbi | $67 | 4 payments
|
| Boston Scientific | Watchman | $54 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $44 | 2 payments
|
| Novo Nordisk | Ozempic | $44 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $13 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Boston Scientific Corporation · S Icd Pas · 2019 | Their institution | $1,038 |
| BOSTON SCIENTIFIC CORPORATION · S Icd Pas · 2020 | Their institution | $508 |
Professional record
- NPI
- 1598721698
- Licence
- CA G41464California G41464: Current · expires 2027-10-31
- Trained
- Stanford University School of Medicine, 1979
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-04-26
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.